Navigation Links
Accumetrics, Inc. Announces Endotech SPA as Exclusive Distributor for the VerifyNow System in Italy
Date:9/15/2009

SAN DIEGO, Sept. 15 /PRNewswire/ -- Accumetrics, Inc. announces today it has signed a new exclusive agreement with Endotech SPA for distribution of its VerifyNow(R) System in Italy. With the addition of Endotech to Accumetrics' growing number of distribution partners, Accumetrics now has local representation in 25 countries in Europe, Latin America and Asia / Pacific.

The VerifyNow System helps physicians assess patients' response to life-saving antiplatelet therapies, such as aspirin, Plavix(R), Effient (R), and GP IIb/IIIa inhibitors. As response to these drugs varies, the tests help physicians ensure their patients on antiplatelet medications are receiving the optimal benefit.

"We're pleased that Endotech will now oversee the Italian distribution of our VerifyNow System. The company's knowledge of the cardiology market in Italy is unparalleled," said Timothy I. Still, President and CEO of the Company. "Physicians worldwide have a need for the critical information that is provided by the VerifyNow System. We are enthusiastic about Endotech's ability to bring our value to the Italian market."

"We have already experienced significant interest in the VerifyNow System and look forward to the continued growth of our relationship with Accumetrics in the Italian market," said Aldo Pagani, President and CEO of Endotech SPA. "We believe that our understanding of the value the VerifyNow System brings to physicians coupled with our expertise in marketing and sales strategy in Italy will be the key to our mutual success."

About Accumetrics (www.accumetrics.com)

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.

Accumetrics' VerifyNow System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, P2Y12 inhibitors (e.g. prasugrel (Effient) and clopidogrel (Plavix)), and the GP IIb/IIIa inhibitors (e.g. ReoPro(R) and Integrilin(R)), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.

The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of sanofi-aventis. Effient is a registered trademark of Lilly-Daiichi Sankyo.

About Endotech SPA (www.endotech.it)

Endotech SPA is an Italian company distributing medical devices and equipment designed for cardiovascular physicians. The company specializes in the distribution and launch of innovative medical instrumentation technology and maintains a strong presence in the Italian market, offering optimized logistics and excellent technical and scientific support. Endotech SPA is UNI EN ISO 13485:2004 and 9001:2008 certified.

    CONTACT:
    Adam J. Handelsman
    Lippert/Heilshorn & Associates
    212-838-3777
    ahandelsman@lhai.com

    Timothy I. Still
    President and CEO
    Accumetrics
    858-404-8260
    press@accumetrics.com


'/>"/>
SOURCE Accumetrics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Accumetrics, Inc. Forms Partnership With Grifols as Its Distributor in Spain, Portugal and Chile
2. Accumetrics, Inc. Announces Distribution Channels in Israel and Cyprus
3. Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial
4. Accumetrics, Inc. Announces United Kingdom Distribution Agreement With ELITech UK Limited
5. Gregory J. Tibbitts Appointed Chief Financial Officer at Accumetrics, Inc.
6. Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.
7. Accumetrics, Inc. Appoints William Dippel as Executive Vice President of Operations and R&D
8. Caraco Pharmaceutical Laboratories, Ltd. Announces Appointment of F. Folsom Bell to Board of Directors
9. Advanced Life Sciences Announces Restanza(TM) Granted FDA Orphan Drug Designation for Plague and Tularemia
10. Accuray Announces Additions to Board of Directors
11. Palatin Technologies, Inc. Announces PL-3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Vegas, NV (PRWEB) , ... April 25, 2017 ... ... can now choose a modern procedure that achieves results in a fraction of ... in Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary ...
(Date:4/25/2017)... GA (PRWEB) , ... April 25, 2017 , ... ... their neck and back pain with a reputable physician in their area, announces the ... CRM protects patient information for patients who are looking for reputable physicians to help ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical ... patients in Nashville , Tennesse have ... Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. The ... provide long-term reflux control by restoring normal function to ... 65 million people in the United States ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
Breaking Medicine Technology: